201. Early treatment of corneal abrasions and ulcers-estimating clinical and economic outcomes.
- Author
-
Rathi VM, Thokala P, MacNeil S, Khanna RC, Monk PN, and Garg P
- Abstract
Background: In low-and-middle income countries, corneal abrasions and ulcers are common and not always well managed. Previous studies showed better clinical outcomes with early presentation and treatment of minor abrasions, however, there have been no formal studies estimating the financial impact of early treatment of abrasions and ulcers compared to delayed treatment., Methods: We used the LV Prasad Eye Institute's (LVPEI's) electronic health record system (eyeSmart) to estimate the impact of early presentation on clinical outcomes associated with abrasions and ulcers. 861 patients with corneal abrasion and 1821 patients with corneal ulcers were studied retrospectively, and 134 patients with corneal abrasion prospectively. A health economic model was constructed based on LVPEI cost data for a range of patient scenarios (from early presentation with abrasion to late presentation with ulcer)., Findings: Our findings suggest that delayed presentation of corneal abrasion results in poor clinical and economic outcomes due to increased risk of ulceration requiring more extensive surgical management, increasing associated costs to patients and the healthcare system. However, excellent results at low cost can be achieved by treatment of patients with early presentation of abrasions at village level health care centres., Interpretation: Treatment of early minor corneal abrasions, particularly using local delivery of treatment, is effective clinically and economically . Future investment in making patients aware of the need to react promptly to corneal abrasions by accessing local healthcare resources (coupled with a campaign to prevent ulcerations occurring) will continue to improve clinical outcomes for patients at low cost and avoid complex and more expensive treatment to preserve sight., Funding: This research was funded by the Medical Research Council, grant MR/S004688/1., Competing Interests: PM reports funding for the current study from Medical Research Council and PM is a co-inventor on a patent (WO2021175809 02/03/21) for a new treatment for epithelial infections. The treatment is not mentioned here. PG has reported grant from Indian Council of Medical Research, Department of biotechnology, Government of India in Institute's name. RCK has reported grant from Lions Club International SightFirst Research Grant (SFP2170/UND) and United States Agency for International Development (USAID) (Grant No CBP 033) in Institute's name. Rest of the authors declare no competing interests., (© 2022 The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF